Literature DB >> 8018400

Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer.

R A Badwe1, D Y Wang, W M Gregory, I S Fentiman, M A Chaudary, P Smith, M A Richards, R D Rubens.   

Abstract

Serum progesterone and oestradiol levels have been measured in 210 premenopausal women with operable breast cancer on samples taken within 3 days of tumour excision. There was no relation between oestradiol level and time since last menstrual period, nor any effect of oestradiol value on prognosis. However, serum progesterone levels were related to the phase of the cycle as determined by time since last menstrual period. When divided on a basis of levels > 1.5 ng/ml (luteal phase) and < or = 1.5 ng/ml, it was found that there was no difference in survival between the two groups among 117 axillary node negative cases. However, in the 93 patients with positive axillary nodes, higher progesterone levels were associated with significantly better survival. Thus, serum progesterone levels at the time of surgery may affect the prognosis of premenopausal node positive patients with operable breast cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018400     DOI: 10.1016/0959-8049(94)90415-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors:  R A Badwe; I Mittra; R Havaldar
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

2.  Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.

Authors:  Clive S Grant; James N Ingle; Vera J Suman; Daniel A Dumesic; D Lawrence Wickerham; Richard D Gelber; Patrick J Flynn; Lorna M Weir; Mattia Intra; Wayne O Jones; Edith A Perez; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

3.  Serum progesterone and prognosis in operable breast cancer.

Authors:  P E Mohr; D Y Wang; W M Gregory; M A Richards; I S Fentiman
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

4.  Characteristics of the menstrual cycle at the time of surgery for breast cancer.

Authors:  I M Holdaway; B H Mason; A E Lethaby; J E Harman; J T France; B S Knox
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  The Relationship between Surgery and Phase of the Menstrual Cycle Affects Survival in Breast Cancer.

Authors:  Ali Imran Kucuk; Can Atalay
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

6.  Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update.

Authors:  Anushka Chaudhry; Michael L Puntis; Panos Gikas; Kefah Mokbel
Journal:  Int Semin Surg Oncol       Date:  2006-11-01

7.  Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study.

Authors:  H Thorpe; S R Brown; J R Sainsbury; T J Perren; V Hiley; M Dowsett; A Nejim; J M Brown
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

8.  An interferon signature identified by RNA-sequencing of mammary tissues varies across the estrous cycle and is predictive of metastasis-free survival.

Authors:  Antoine M Snijders; Sasha Langley; Jian-Hua Mao; Sandhya Bhatnagar; Kathleen A Bjornstad; Chris J Rosen; Alvin Lo; Yurong Huang; Eleanor A Blakely; Gary H Karpen; Mina J Bissell; Andrew J Wyrobek
Journal:  Oncotarget       Date:  2014-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.